Mar 30, 2021
Restrictive Vs Liberal transfusion strategy debate has come to the surface after the publication of the REALITY trial. In this podcast, we dive deeper into proposed transfusion thresholds in intensive care in various subgroups and the evidence behind them.
Mar 23, 2021
Hemoglobin targets in patients with myocardial infarction are still debatable. In this episode, we discuss the landmark REALITY trial, which explores the non-inferiority of a restrictive transfusion strategy over a liberal transfusion strategy.
Mar 15, 2021
In this episode, we discuss recently published practice-changing trials RECOVERY and REMAP-CAP. These trials have clearly demonstrated the difference in mortality with the use of Tocilizumab in severe COVID-19.
Mar 4, 2021
Join us to dive deeper into the recent controversy around oxygen therapy and its proposed targets in ICU patients. In this episode, we compare 3 landmark trials namely ICU-ROX, LOCO2 and HOT-ICU along with recently published meta-analyses to fully understand the nature of this controversy and discuss...